Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

The Effect of Golimumab Therapy on Disease Activity and Health-related Quality of Life in Patients with Ankylosing Spondylitis: 2-year Results of the GO-RAISE Trial

Désirée van der Heijde, Atul Deodhar, Jürgen Braun, Michael Mack, Benjamin Hsu, Timothy A. Gathany, Robert D. Inman, Chenglong Han and The GO-RAISE investigators
The Journal of Rheumatology June 2014, 41 (6) 1095-1103; DOI: https://doi.org/10.3899/jrheum.131003
Désirée van der Heijde
From the Rheumatology Department, Leiden University Medical Center, Leiden, The Netherlands; Oregon Health and Science University, Portland, Oregon, USA; Rheumazentrum Ruhrgebiet, Herne, Germany; Biostatistics and Immunology, Janssen Research & Development LLC, Spring House; Janssen Global Services, Malvern, Pennsylvania, USA; Department of Medicine and Immunology, University of Toronto, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: d.vanderheijde@kpnplanet.nl
Atul Deodhar
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jürgen Braun
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Mack
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Hsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Timothy A. Gathany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert D. Inman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chenglong Han
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Information

vol. 41 no. 6 1095-1103
DOI 
https://doi.org/10.3899/jrheum.131003
PubMed 
24737912

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Accepted for publication February 12, 2014
  • Published online June 1, 2014.

Article Versions

  • Latest version (April 15, 2014 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2014

Author Information

  1. Désirée van der Heijde⇑,
  2. Atul Deodhar,
  3. Jürgen Braun,
  4. Michael Mack,
  5. Benjamin Hsu,
  6. Timothy A. Gathany,
  7. Robert D. Inman,
  8. Chenglong Han,
  9. The GO-RAISE investigators
  1. From the Rheumatology Department, Leiden University Medical Center, Leiden, The Netherlands; Oregon Health and Science University, Portland, Oregon, USA; Rheumazentrum Ruhrgebiet, Herne, Germany; Biostatistics and Immunology, Janssen Research & Development LLC, Spring House; Janssen Global Services, Malvern, Pennsylvania, USA; Department of Medicine and Immunology, University of Toronto, Toronto, Ontario, Canada.
  2. D. van der Heijde, MD, Rheumatology Department, Leiden University Medical Center; A. Deodhar, MD, Oregon Health & Science University; J. Braun, MD, Rheumazentrum Ruhrgebiet; M. Mack, PhD, Biostatistics, Janssen Research & Development LLC; B. Hsu, MD, PhD, Immunology, Janssen Research & Development LLC; T.A. Gathany, MSEd, Janssen Global Services; R.D. Inman, MD, FRCPC, FACP, FRCP Edin, Department of Medicine and Immunology, University of Toronto; C. Han, PhD, Janssen Global Services.
  1. Address correspondence to Dr. D. van der Heijde, Rheumatology Department, Leiden University Medical Center, PO Box 9600, 2300 RC, Leiden, The Netherlands. E-mail: d.vanderheijde{at}kpnplanet.nl

Article usage

Article usage: April 2014 to May 2022

AbstractFullPdf
Apr 2014254198
May 2014133439
Jun 201461538134
Jul 20141611838
Aug 20141161619
Sep 201483915
Oct 2014621113
Nov 2014701626
Dec 201440611
Jan 2015521017
Feb 20153898
Mar 2015461214
Apr 2015421210
May 2015331011
Jun 2015491215
Jul 2015241011
Aug 2015241211
Sep 20152088
Oct 2015241014
Nov 20152612
Dec 2015221413
Jan 201626715
Feb 20161567
Mar 201632913
Apr 20162523
May 20162256
Jun 20162022
Jul 201615712
Aug 20162244
Sep 20161866
Oct 20162412
Nov 201627218
Dec 20163868
Jan 20173367
Feb 201729206
Mar 20173764
Apr 20174155
May 20172799
Jun 201741117
Jul 20173542
Aug 2017311112
Sep 20173911
Oct 20173165
Nov 201763109
Dec 20176853
Jan 2018431810
Feb 20186675
Mar 20184364
Apr 20184953
May 20187253
Jun 20182642
Jul 20182523
Aug 20182096
Sep 20182895
Oct 20181966
Nov 20185963
Dec 20182163
Jan 20195212
Feb 20193201
Mar 20191654
Apr 20192841
May 20192233
Jun 20191216
Jul 20195755
Aug 201936912
Sep 20193152
Oct 20194678
Nov 20194055
Dec 20193894
Jan 20203574
Feb 202053216
Mar 202031613
Apr 202010209
May 202042014
Jun 20204710
Jul 20201288
Aug 2020669
Sep 202071810
Oct 2020579
Nov 202031111
Dec 20208188
Jan 202141012
Feb 202193013
Mar 2021748
Apr 202141813
May 202145910
Jun 202122116
Jul 20211136
Aug 202111614
Sep 202141810
Oct 20212186
Nov 202131719
Dec 20211326
Jan 202211311
Feb 202211010
Mar 20224636
Apr 202255513
May 202202119

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 6
1 Jun 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Effect of Golimumab Therapy on Disease Activity and Health-related Quality of Life in Patients with Ankylosing Spondylitis: 2-year Results of the GO-RAISE Trial
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The Effect of Golimumab Therapy on Disease Activity and Health-related Quality of Life in Patients with Ankylosing Spondylitis: 2-year Results of the GO-RAISE Trial
Désirée van der Heijde, Atul Deodhar, Jürgen Braun, Michael Mack, Benjamin Hsu, Timothy A. Gathany, Robert D. Inman, Chenglong Han, The GO-RAISE investigators
The Journal of Rheumatology Jun 2014, 41 (6) 1095-1103; DOI: 10.3899/jrheum.131003

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
The Effect of Golimumab Therapy on Disease Activity and Health-related Quality of Life in Patients with Ankylosing Spondylitis: 2-year Results of the GO-RAISE Trial
Désirée van der Heijde, Atul Deodhar, Jürgen Braun, Michael Mack, Benjamin Hsu, Timothy A. Gathany, Robert D. Inman, Chenglong Han, The GO-RAISE investigators
The Journal of Rheumatology Jun 2014, 41 (6) 1095-1103; DOI: 10.3899/jrheum.131003
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

GOLIMUMAB
ANKYLOSING SPONDYLITIS
HEALTH-RELATED QUALITY OF LIFE
PRODUCTIVITY
ASDAS

Related Articles

Cited By...

More in this TOC Section

  • Melorheostosis or "Dripping Candle Wax" Bone Disease
  • IgG4-related Disease Mimicking a Paratesticular Tumor and Pelvic Lymph Node Metastasis
  • Microstructural Evidence of Neuroinflammation for Psychological Symptoms and Pain in Patients With Fibromyalgia
Show more Article

Similar Articles

Keywords

  • GOLIMUMAB
  • ankylosing spondylitis
  • health-related quality of life
  • PRODUCTIVITY
  • ASDAS

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire